Bad Drug » Riata Defibrillator Recall
The U.S. Food and Drug Administration has recalled St. Jude Medical, Inc.’s Riata defibrillator lead over potential risks of injury or death. The company took Riata off the market last year; however, about 79,000 devices are still in use. Riata has been linked to incidents in which wires that run from the device to the heart may poke through the outer coating of their cable, which could result in the device failing to deliver a shock or, conversely, shocking patients unnecessarily.
St. Jude sent doctors a voluntary medical device advisory letter on Nov. 28 regarding the Riata defibrillator deficiencies. In the letter, St. Jude said a flaw with the wires on the Riata defibrillator is more prevalent than previously thought.
When the device was taken off the market in Dec. 2010, St. Jude said the rate of abrasion was 0.47 percent nine years after the original implantation, with 0.047 percent demonstrating “externalized cables.” In its most recent letter to physicians, St. Jude increased the abrasion rate to 0.63 percent.
A study of 212 patients in Ireland who received St. Jude’s Riata defibrillator lead found that 15 percent had suffered such an “insulation breach,” which could interfere with the device’s lifesaving therapy.
Recipients of the recalled Riata leads are advised to consult with their physician as soon as possible. Doctors may design individual treatment plans for those with damaged wires based on their risk level.
The company is not advising all affected patients to have their leads removed or replaced, as attempts at removing these leads can result in injury and death. However, those who are experiencing electrical abnormalities may be advised to have their leads replaced or removed. Patients risk their safety when having the leads taken out, but they also risk their lives if their leads malfunction.
If a malfunctioning Riata lead has caused you or a loved one to experience cardiac difficulty, fill out the contact form to the right to consult with one of our medical lawyers
A Class I recall from the FDA indicates that use of the medical device will likely result in serious injury, illness or death. The recall includes about 79,000 devices still in use at the time of the initial announcement. Malfunctions associated with Riata and Riata ST Silicone defibrillators have resulted in two deaths and one serious injury.
The following devices are included in the Class I recall:
Riata (8F) Silicone Endocardial Defibrillation Leads
Models:
Riata ST (7Fr) Silicone Endocardial Defibrillation Leads
Models:
Contacting this site does not constitute an attorney - client relationship. An attorney - client relationship can be created in a written agreement.
The information included on this site is for educational purposes only. It is not intended nor implied to be a substitute for professional medical advice. The reader should always consult his or her healthcare provider. Reading the information on this website does not create a physician-patient relationship.
Copyright © © 2025 deciBel Publishing. All rights reserved.
Sitemap | Call a Lawyer
Latest FDA News
Endoscopic Vessel Harvesting (EVH) System Correction: Getinge and Maquet Cardiovascular Update Use Instructions for VasoView HemoPro 2 (VH-4000 and VH-4001) EVH Systems due to Risk for Bent or Detached Heater Wires and Silicone Peeling or Detaching During UseHemoPro EVH Systems have updated instructions related to bent/detached heater wires and peeling/detaching silicone during minimally invasive surgery.
Find us on Google+